What is the current Surgical Biopsy Needles market size?

The current Surgical Biopsy Needles market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Surgical Biopsy Needles market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing cancer cases.

What are the key drivers of the Surgical Biopsy Needles market?

Key drivers include rising demand for minimally invasive procedures and technological advancements.

What are the major challenges facing the Surgical Biopsy Needles market?

Challenges include high costs, limited reimbursement, and stringent regulatory requirements.

Which regions are leading the Surgical Biopsy Needles market?

North America and Europe are leading the market due to advanced healthcare infrastructure.

Who are the top companies in the Surgical Biopsy Needles market?

Top companies include Medtronic, Boston Scientific, and Becton Dickinson, offering a range of biopsy needles.

What are the future opportunities in the Surgical Biopsy Needles market?

Future opportunities include emerging markets and increasing adoption of robotic-assisted biopsies.

How is technology impacting the Surgical Biopsy Needles market?

Technological advancements, such as core needle biopsies, are improving diagnostic accuracy and patient outcomes.

What is the current regulatory landscape for the Surgical Biopsy Needles market?

The market is regulated by FDA and CE mark clearances, ensuring safety and efficacy of biopsy needles.

Why Is the Surgical Biopsy Needles Market Growing So Fast? 2026 Analysis

Surgical Biopsy Needles by Application (Hospital, Clinic, Other), by Types (Bone Cement Needle, Bone Biopsy Needle, Shotgun Biopsy Needle, Lung Biopsy Needle, Aspiration Needle), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Surgical Biopsy Needles Market Size | CAGR 7.8 Forecast 2033

Why Is the Surgical Biopsy Needles Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Surgical Biopsy Needles Market Overview

The Surgical Biopsy Needles market refers to the global market for needles used in surgical biopsies, a crucial diagnostic procedure for various medical conditions. The Surgical Biopsy Needles market size is estimated to be around $650 million in 2025. As the healthcare industry continues to evolve, the Surgical Biopsy Needles market is expected to experience significant growth, driven by an increasing demand for minimally invasive diagnostic procedures. The growth outlook for the Surgical Biopsy Needles market is positive, with a forecasted compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, resulting in a market forecast of over $1.1 billion by 2033. This industry expansion can be attributed to advancements in medical technology, an aging population, and the rising incidence of chronic diseases, which are driving the demand for surgical biopsy needles. Key synonyms for this market include fine-needle aspiration biopsy needles and core needle biopsy needles.

Loading chart…

The Surgical Biopsy Needles market is shaped by several key forces, including technology shifts towards minimally invasive procedures, regulatory requirements for safety and efficacy, and consumer behavior driven by an increasing awareness of diagnostic procedures. The largest region for the Surgical Biopsy Needles market is North America, driven by the presence of major medical device manufacturers and a high demand for diagnostic procedures. The fastest-growing region is expected to be the Asia-Pacific, driven by an increasing healthcare expenditure and a growing awareness of diagnostic procedures. Overall, the Surgical Biopsy Needles market is expected to experience significant growth, driven by macro drivers such as an aging population and the rising incidence of chronic diseases.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Amecath; Mermaid Medical; Ace Medical Devices; AprioMed; Teleflex; Zamar Biopsy; Mammotome; Argon Medical; Hologic; Dr. Japan Co., Ltd.; BPB MEDICA; Mdl Srl; Medax; IZI Medical; Sterylab; UROMED; Weigao Holding; Zhejiang Kindly MEDICAL Devices; Chamfond Biotech; Hangzhou Likang Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Surgical Biopsy Needles market is poised for significant growth, driven by increasing demand for minimally invasive procedures and advancements in needle technology. The Surgical Biopsy Needles market size is expected to expand substantially over the forecast period, with a promising growth forecast.

Growth Drivers2 items

Advances in needle design and materials are improving the accuracy and safety of biopsies, driving adoption of Surgical Biopsy Needles among healthcare providers

The rising incidence of cancer and other diseases requiring biopsy diagnosis is fueling demand for Surgical Biopsy Needles, contributing to the market's growth forecast

Restraints2 items

Stringent regulatory requirements and high development costs are limiting the entry of new players in the Surgical Biopsy Needles market, potentially hindering market growth

The risk of needle-related complications, such as bleeding and infection, is a concern for patients and healthcare providers, which may restrain the adoption of Surgical Biopsy Needles

Opportunities2 items

The increasing demand for Surgical Biopsy Needles in emerging economies presents a significant opportunity for market players to expand their presence and drive revenue growth

The development of innovative, cost-effective Surgical Biopsy Needles with advanced features, such as improved needle guidance and tissue sampling, can help companies differentiate themselves and gain a competitive edge in the market

Challenges2 items

The Surgical Biopsy Needles market is highly competitive, with several established players, making it challenging for new entrants to gain market share and for existing players to maintain their position

The need for ongoing investment in research and development to stay ahead of the competition and address the evolving needs of healthcare providers and patients is a significant challenge for companies operating in the Surgical Biopsy Needles market

Market Segmentation

Loading chart…

The Surgical Biopsy Needles market can be segmented based on application, which includes various medical specialties such as oncology, gastroenterology, and neurology. This segmentation helps in understanding the demand for Surgical Biopsy Needles in different medical fields, contributing to the overall market size. The application segment is crucial in Surgical Biopsy Needles segmentation as it determines the type of needle required for a specific procedure.

The Types of Surgical Biopsy Needles include core needle biopsy, fine-needle biopsy, and vacuum-assisted biopsy, among others. Each type has its own set of subtypes, such as [object Object] and [object Object], which cater to specific medical requirements. Understanding these types and subtypes is essential for market players to develop targeted products, ultimately influencing the overall Surgical Biopsy Needles market size. Analyzing the market taxonomy, including Surgical Biopsy Needles segmentation, is vital for businesses to make informed decisions.

Surgical Biopsy Needles Segmentation Breakdown10 items

Application

Hospital

Clinic

Other

Types

Bone Cement Needle

Bone Biopsy Needle

Shotgun Biopsy Needle

Lung Biopsy Needle

Aspiration Needle

Regional Insights

Loading chart…

The Surgical Biopsy Needles market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The regional forecast indicates that Asia Pacific will be the fastest-growing region, driven by increasing adoption of advanced medical technologies, investments in healthcare infrastructure, and a growing demographics of older population.

Key drivers for each region include: for North America, policies supporting cancer research, infrastructure development in hospitals, and ecosystem maturity of medical device manufacturers. For Europe, factors such as adoption of minimally invasive procedures, investments in research and development, and demographics of an aging population contribute to the market growth. In Asia Pacific, infrastructure development, policies supporting healthcare access, and ecosystem maturity of medical technology companies drive the market.

Latin America and Middle East & Africa also present opportunities for Surgical Biopsy Needles market growth, driven by adoption of advanced medical technologies, investments in healthcare infrastructure, and a growing demographics of younger population. However, these regions face challenges such as limited infrastructure, policies supporting healthcare access, and ecosystem maturity of medical device manufacturers.

Competitive Landscape

The Surgical Biopsy Needles market is moderately consolidated, driven by a mix of global players and local/regional companies. The Surgical Biopsy Needles competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on premium pricing and innovative products, while local companies emphasize cost advantages and regional expansion.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Companies differentiate themselves through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting to these challenges by focusing on specific strategic areas, including:

BD: regional expansion

Amecath: innovation pipeline

Mermaid Medical: premium pricing

Ace Medical Devices: OEM tie-ups

AprioMed: local manufacturing

Teleflex: vertical integration

Key Surgical Biopsy Needles Companies21 items

Amecath

Mermaid Medical

Ace Medical Devices

AprioMed

Teleflex

Zamar Biopsy

Mammotome

Argon Medical

Hologic

Dr. Japan Co., Ltd.

BPB MEDICA

Mdl Srl

Medax

IZI Medical

Sterylab

UROMED

Weigao Holding

Zhejiang Kindly MEDICAL Devices

Chamfond Biotech

Hangzhou Likang Medical Technology

Market Ecosystem

The Surgical Biopsy Needles ecosystem encompasses a complex network of upstream, midstream, and downstream participants. Upstream, technology providers and suppliers deliver essential components and materials, while midstream integrators and manufacturers produce the biopsy needles. Downstream, channels and end users interact to create and capture value. Understanding this ecosystem is crucial for conducting a thorough value chain analysis.

Raw material suppliers — provide needle materials

OEMs / manufacturers — produce biopsy needles

Distributors / channel partners — supply to healthcare facilities

End users / buyers — healthcare professionals and patients

Regulators/standards bodies — establish safety and efficacy standards

Service providers / after-sales — offer maintenance and support

Data/analytics providers — track usage and outcomes

In the Surgical Biopsy Needles ecosystem, control points are largely influenced by regulators and standards bodies, as well as the purchasing decisions of end users. Dependency risks arise from input constraints, such as the availability of raw materials, and the need for approvals from regulatory bodies. Switching costs and partnerships can also impact the ecosystem, particularly in terms of interoperability requirements between different needle systems. Furthermore, regional differences in the ecosystem may exist due to varying regulatory frameworks and market conditions.

Recent Industry Insights

The Surgical Biopsy Needles industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on advancing needle technology and improving patient outcomes. Notable mergers and acquisitions have also taken place, with companies like Medtronic and Boston Scientific expanding their product portfolios. Furthermore, several product launches have introduced innovative features such as improved needle design and enhanced imaging capabilities.

In addition to these developments, regulatory changes have emphasized the importance of patient safety and device efficacy. A shift in consumer trends has also been observed, with a growing demand for minimally invasive procedures and personalized medicine. Funding rounds and expansions have supported the growth of startups and small businesses in the Surgical Biopsy Needles market, driving innovation and competition.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Surgical Biopsy Needles market outlook. The market attractiveness is moderate, driven by the increasing prevalence of chronic diseases and the growing need for diagnostic procedures. The competitive intensity is high, with key players competing on the basis of product quality, pricing, and innovation. The long-term outlook is positive, with the market expected to grow at a steady rate due to the rising demand for minimally invasive procedures.

The innovation landscape is rapidly evolving, with a focus on developing advanced biopsy needles with improved accuracy and reduced complications. The demand-supply balance is expected to be stable, with manufacturers increasing production to meet the growing demand. However, key risk factors such as regulatory changes and competition from alternative diagnostic technologies may impact the market. Overall, the Surgical Biopsy Needles market is expected to experience steady growth, driven by the increasing demand for diagnostic procedures and the development of innovative products.

11 items

1. Executive Summary

2. Surgical Biopsy Needles Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Surgical Biopsy Needles Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Surgical Biopsy Needles Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Other

6.2. Global Surgical Biopsy Needles Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Bone Cement Needle

6.2.2. Bone Biopsy Needle

6.2.3. Shotgun Biopsy Needle

6.2.4. Lung Biopsy Needle

6.2.5. Aspiration Needle

6.3. Global Surgical Biopsy Needles Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Surgical Biopsy Needles Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Surgical Biopsy Needles Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Surgical Biopsy Needles Market Competition by Key Manufacturers

8.1. Global Surgical Biopsy Needles Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Surgical Biopsy Needles: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Amecath

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Mermaid Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Ace Medical Devices

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. AprioMed

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Teleflex

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Zamar Biopsy

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Mammotome

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Argon Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Hologic

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Dr. Japan Co., Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. BPB MEDICA

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Mdl Srl

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Medax

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. IZI Medical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Sterylab

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. UROMED

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Weigao Holding

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Zhejiang Kindly MEDICAL Devices

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Chamfond Biotech

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Hangzhou Likang Medical Technology

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Surgical Biopsy Needles Market

Figure 4: Global Surgical Biopsy Needles Market: Drivers

Figure 5: Global Surgical Biopsy Needles Market: Challenges

Figure 6: Global Surgical Biopsy Needles Market: Trends

Figure 7: Global Surgical Biopsy Needles Market: Opportunity

Figure 8: Global Surgical Biopsy Needles Market: Restraint

Figure 9: Global Surgical Biopsy Needles Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Surgical Biopsy Needles Market Value (USD Million) By Region

Figure 15: Global Surgical Biopsy Needles Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Surgical Biopsy Needles Market Value (USD Million) By Region

Figure 23: Global Surgical Biopsy Needles Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global Surgical Biopsy Needles Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Surgical Biopsy Needles Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Surgical Biopsy Needles Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Surgical Biopsy Needles Market Value (USD Million) By Region

Table 10: Global Surgical Biopsy Needles Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Surgical Biopsy Needles Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Surgical Biopsy Needles Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Surgical Biopsy Needles Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: Amecath Basic Information And Sales Area

Table 33: Amecath. Products Portfolio

Table 34: Mermaid Medical Basic Information And Sales Area

Table 35: Mermaid Medical. Products Portfolio

Table 36: Ace Medical Devices Basic Information And Sales Area

Table 37: Ace Medical Devices. Products Portfolio

Table 38: AprioMed Basic Information And Sales Area

Table 39: AprioMed. Products Portfolio

Table 40: Teleflex Basic Information And Sales Area

Table 41: Teleflex. Products Portfolio

Table 42: Zamar Biopsy Basic Information And Sales Area

Table 43: Zamar Biopsy. Products Portfolio

Table 44: Mammotome Basic Information And Sales Area

Table 45: Mammotome. Products Portfolio

Table 46: Argon Medical Basic Information And Sales Area

Table 47: Argon Medical. Products Portfolio

Table 48: Hologic Basic Information And Sales Area

Table 49: Hologic. Products Portfolio

Table 50: Dr. Japan Co., Ltd. Basic Information And Sales Area

Table 51: Dr. Japan Co., Ltd.. Products Portfolio

Table 52: BPB MEDICA Basic Information And Sales Area

Table 53: BPB MEDICA. Products Portfolio

Table 54: Mdl Srl Basic Information And Sales Area

Table 55: Mdl Srl. Products Portfolio

Table 56: Medax Basic Information And Sales Area

Table 57: Medax. Products Portfolio

Table 58: IZI Medical Basic Information And Sales Area

Table 59: IZI Medical. Products Portfolio

Table 60: Sterylab Basic Information And Sales Area

Table 61: Sterylab. Products Portfolio

Table 62: UROMED Basic Information And Sales Area

Table 63: UROMED. Products Portfolio

Table 64: Weigao Holding Basic Information And Sales Area

Table 65: Weigao Holding. Products Portfolio

Table 66: Zhejiang Kindly MEDICAL Devices Basic Information And Sales Area

Table 67: Zhejiang Kindly MEDICAL Devices. Products Portfolio

Table 68: Chamfond Biotech Basic Information And Sales Area

Table 69: Chamfond Biotech. Products Portfolio

Table 70: Hangzhou Likang Medical Technology Basic Information And Sales Area

Table 71: Hangzhou Likang Medical Technology. Products Portfolio

Table 72: Global Market Value (USD Million) (2025-2032) By Application

Table 73: Global Market Share (%) By Application (2032)

Table 74: Global Market Value (USD Million) (2025-2032) By Types

Table 75: Global Market Share (%) By Types (2032)

Table 76: Global Surgical Biopsy Needles Market Value (USD Million) By Region

Table 77: Global Surgical Biopsy Needles Market Share (%) By Region (2025-2032)

Table 78: North America Market Value (USD Million) (2025-2032) By Country

Table 79: North America Market Value (USD Million) (2025-2032) By Application

Table 80: North America Market Value (USD Million) (2025-2032) By Types

Table 81: Europe Market Value (USD Million) (2025-2032) By Country

Table 82: Europe Market Value (USD Million) (2025-2032) By Application

Table 83: Europe Market Value (USD Million) (2025-2032) By Types

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 87: South America Market Value (USD Million) (2025-2032) By Country

Table 88: South America Market Value (USD Million) (2025-2032) By Application

Table 89: South America Market Value (USD Million) (2025-2032) By Types

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Surgical Biopsy Needles Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Amecath; Mermaid Medical; Ace Medical Devices; AprioMed; Teleflex; Zamar Biopsy; Mammotome; Argon Medical; Hologic; Dr. Japan Co., Ltd.; BPB MEDICA; Mdl Srl; Medax; IZI Medical; Sterylab; UROMED; Weigao Holding; Zhejiang Kindly MEDICAL Devices; Chamfond Biotech; Hangzhou Likang Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options